Brief: Spago Nanomedical: US Patent Granted For Tumorad
June 26 (Reuters) - SPAGO NANOMEDICAL AB (PUBL) SPAGO.TE :
* US PATENT GRANTED FOR TUMORAD®
* UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
COMPANY'S PATENT APPLICATION
* PATENT, WITH TITLE "NANOSTRUCTURES AND APPLICATIONS
THEREOF"
* PATENT HAS BEEN ASSIGNED PATENT NUMBER US 9,999,963 AND IS
VALID
UNTIL YEAR 2035
Source text for Eikon: ID:nWkr8JgZkP
Further company coverage: SPAGO.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Spago Nanomedical AB (publ)
See all newsBrief: Spago Nanomedical Announces Outcome Of Rights Issue
Brief: Spago Nanomedical Resolves On Rights Issue Of About SEK 16 Million
Sweden's Spago Nanomedical Q1 loss narrows
Brief: Spago Nanomedical Q1 Sales SEK 22 Thousand
Brief: Spago Nanomedical Says Tumorad-01 Study Meets Primary Endpoint Of Maximum Tolerated Dose